Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L.   Doody R.S.   Pratt R.D.   Ieni J.R.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: An Open-Label, Multicentre, Single-Treatment-Arm Study

By Graff Gavin R.  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 351-364

Adis International

Access to resources Recommend Favorite

Costs of Eprosartan versus Diuretics for Treatment of Hypertension in a Geriatric Population: An Observational, Open-Label, Multicentre Study

By Gregori Joaquin A. Alvarez  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 617-626

Adis International

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use: Open-Label, Prospective Study

By Nguyen M.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite